Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Open-Label, Multicenter Extension Study to Evaluate the Safety of R935788 in Patients With Rheumatoid Arthritis Who Have Completed the Treatment Phase of a Rigel-Sponsored R935788 Study

NCT00805467 is registered in ClinicalTrials.gov with AstraZeneca as lead sponsor.

NCT NCT00805467
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00805467 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Open-Label, Multicenter Extension Study to Evaluate the Safety of R935788 in Patients With Rheumatoid Arthritis Who Have Completed the Treatment Phase of a Rigel-Sponsored R935788 Study
Lead sponsor
AstraZeneca
Phase
Phase 2
Overall status
Terminated
Start date
August 31, 2008
Completion date
August 31, 2013
Enrollment
624 (actual)
Sites
76

Conditions

As the registry lists them; a condition with its own page is linked.

rheumatoid arthritis